TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
MedPage Today published a roundup of health-related comments heard by its reporters on October 25, 2026. The topics included dengue outbreaks, questions about early-life dupilumab exposure, menopause treatments, advance care planning and preliminary Parkinson’s research.
MedPage Today published a weekly roundup of comments from clinicians and researchers on October 25, covering dengue outbreaks, pregnancy exposure to dupilumab, menopause treatments and other medical developments. The collection records experts’ reactions and research observations; it is not a single study or a report that independently verifies each underlying finding.
Adam Waickman, a researcher at SUNY Upstate Medical University, used the phrase “The cat is out of the bag” while discussing large dengue outbreaks in Florida and warning of possible further spread across the United States. The roundup did not provide case counts, a forecast, or details on the locations or timing of potential spread.
Other comments addressed questions raised by research. Christina Chambers of the University of California San Diego said it remained an open question whether early-life exposure to dupilumab, sold as Dupixent, might lower children’s long-term risk of atopic conditions. The roundup said data indicated exposure during pregnancy appeared safe, but did not describe the study design, size or follow-up period.
The remaining quotes touched on several distinct topics: a misdiagnosis of multiple sclerosis discussed by Cleveland Clinic neurologist Marisa McGinley; an exceptionally rare infant case involving a second colon, described by Lynn Sinitsky of an English hospital trust; a meta-analysis of non-hormonal drugs for menopause-related sleep disturbance; advance care planning for people nearing kidney failure; and a small trial of psilocybin in patients with Parkinson’s disease. The source provides brief summaries, not enough detail to assess the underlying evidence independently.
A Snapshot of Health Research Questions
The roundup brings together a range of clinical concerns and research questions that could matter to patients and clinicians, from infectious-disease monitoring to how medical teams record a patient’s care preferences. Its value is as a quick record of what experts were discussing, rather than as a complete account of the evidence behind each topic.
The comments also underline differences in certainty. A warning about dengue spread is not a quantified prediction; an open question about a medication is not proof of a long-term benefit; and findings from a small trial do not establish a treatment effect. Readers should treat the summaries as pointers to developments, not substitutes for the studies or public-health guidance they describe.
dengue prevention mosquito repellent DEET
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Seven Topics in One Roundup
MedPage Today’s item is a quote roundup dated October 25, 2026, rather than a conventional research report. It presents brief remarks gathered by the publication’s reporters and identifies the speakers and, in most cases, their institutions. The source describes the piece as a two-minute read.
The subjects range from a public-health concern—dengue outbreaks in Florida—to research on medication exposure, menopause symptoms and a possible biological effect of psilocybin in Parkinson’s disease. Other entries focus on diagnosis and care: McGinley discussed an incorrect multiple sclerosis diagnosis, while Angelo Volandes of Dartmouth Health described research into a video decision-support tool associated with increased documentation of advance care planning among patients nearing kidney failure.
These items are not presented as one connected development. Each quote refers to a separate issue, and the short format leaves out methods, sample sizes and full results. The source does not supply links to the underlying research in the provided material.
““This is good news for women.””
— JoAnn Manson, MD, MPH, DrPH, Harvard Medical School
menopause nonhormonal sleep support products
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Evidence Details Remain Limited
The roundup does not include the full studies or data behind its summaries. It gives no dengue case totals or forecast, and no details on the pregnancy-exposure data, menopause meta-analysis or advance-care-planning research. It also describes the psilocybin research as a small trial linking the drug with reduced markers of systemic inflammation and mitochondrial stress, without providing sample size, duration or results beyond that description.
Several statements are explicitly qualified. Chambers called the possible long-term effect of early-life dupilumab exposure an open question. The roundup does not establish that the drug lowers future atopic risk. Nor does its brief description of the Parkinson’s trial show that psilocybin improves symptoms or changes disease progression. Further details, including study limitations and independent assessments, are not included in the supplied report.
advance care planning workbook kidney disease
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Follow-Up Depends on the Evidence
The source does not announce a single upcoming milestone for the topics it covers. Readers seeking updates on dengue can look to public-health authorities for current case information and guidance; the roundup itself gives no schedule for further reporting or forecast.
For the research items, the next informative steps would be access to the full studies and any subsequent results, especially longer-term follow-up for questions about medication exposure and larger or replicated trials where early findings are preliminary. The source does not say when such evidence will be available. Until then, the quotes should be read as brief expert comments tied to separate developments, not as final conclusions.
Parkinson's disease caregiver guide
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did MedPage Today publish on October 25, 2026?
It published a weekly collection of quotes from clinicians and researchers on several medical topics, including dengue outbreaks, medication research and patient care.
Does the roundup confirm that dengue will spread across the United States?
No. Adam Waickman warned of further spread, but the supplied roundup gives no quantified forecast, case count or specific locations beyond noting large outbreaks in Florida.
Does dupilumab exposure in pregnancy lower a child’s future risk of atopic conditions?
The roundup does not establish that. Christina Chambers described the possible long-term effect of early-life exposure as an open question; the source says pregnancy exposure appeared safe but provides no study details.
What did the roundup say about menopause treatments?
It cited JoAnn Manson’s comment on a meta-analysis reporting that non-hormonal menopause drugs can ease sleep disturbances. The brief item does not identify the drugs or provide the analysis’s methods and results.
Did the psilocybin trial prove a benefit for Parkinson’s disease?
No. The source describes a small trial that linked psilocybin with reduced markers of systemic inflammation and mitochondrial stress. It does not report proof of symptom improvement or disease modification.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
